AI has revolutionized the medical field, from alleviating the manpower needed for administrative tasks to providing huge advancements in the medical device space. Biotech companies are now using AI and machine learning to expedite the drug discovery process, with the potential to create dozens of new medicines in the next decade. AI is significantly cutting down the timeline of the drug discovery process by combing through vast data sets to quickly identify patient response markers and create viable drug targets more cheaply and efficiently.